Vigil Neuroscience
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $1,934 |
Gross Profit | -113 | -113 | 1,821 | |
EBITDA | -20,562 | -22,365 | -21,302 | -23,744 |
EBIT | -20,676 | -22,478 | -21,415 | -23,857 |
Net Income | -19,258 | -21,227 | -19,940 | -22,174 |
Net Change In Cash | 0 | 0 | 0 | 1,934 |
Free Cash Flow | 4,301 | -15,507 | -21,881 | -15,523 |
Cash | 44,896 | 37,312 | 51,761 | 51,992 |
Basic Shares | 40,577 | 40,564 | 39,864 | 38,832 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -399 | -1,010 | -345 |
EBITDA | -88,467 | -68,806 | -42,381 |
EBIT | -88,866 | -68,884 | -42,409 |
Net Income | -82,638 | -67,726 | -43,252 |
Net Change In Cash | 0 | 0 | 0 |
Cost of Revenue | 95,185 | ||
Free Cash Flow | -71,037 | -66,070 | -39,551 |
Cash | 51,992 | 186,605 | 91,420 |
Basic Shares | 38,712 | 31,685 | 1,531 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.47 |
2024-06-30 | -$0.52 |
2024-03-31 | -$0.50 |
2023-12-31 | -$0.57 |
